| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,575 |
2,965 |
$136K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,383 |
1,129 |
$70K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
440 |
395 |
$26K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
752 |
708 |
$19K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
855 |
677 |
$15K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,537 |
2,116 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
934 |
728 |
$15K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,469 |
1,240 |
$14K |
| 96160 |
|
359 |
319 |
$9K |
| 92552 |
|
415 |
374 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
71 |
67 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
57 |
46 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
41 |
41 |
$3K |
| 81025 |
|
554 |
475 |
$3K |
| 36416 |
|
1,852 |
1,550 |
$2K |
| 80305 |
|
425 |
355 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
40 |
38 |
$2K |
| 99173 |
|
329 |
297 |
$2K |
| 81003 |
|
809 |
690 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
829 |
672 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
76 |
72 |
$1K |
| 69210 |
|
32 |
27 |
$1K |
| 3008F |
|
344 |
337 |
$970.00 |
| 87807 |
|
80 |
70 |
$669.25 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
62 |
59 |
$590.42 |
| 99201 |
|
18 |
18 |
$549.58 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
271 |
204 |
$522.02 |
| 96127 |
|
115 |
104 |
$465.95 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
79 |
74 |
$425.10 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
240 |
190 |
$407.79 |
| 1159F |
|
94 |
92 |
$400.00 |
| 1160F |
|
90 |
88 |
$390.00 |
| 93000 |
|
26 |
26 |
$356.91 |
| 87430 |
|
65 |
33 |
$352.18 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
23 |
16 |
$152.55 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
264 |
234 |
$108.89 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
12 |
12 |
$91.02 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
15 |
14 |
$0.00 |
| 3078F |
|
45 |
43 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
14 |
13 |
$0.00 |
| 99000 |
|
432 |
352 |
$0.00 |
| 3074F |
|
37 |
36 |
$0.00 |
| 3044F |
|
19 |
19 |
$0.00 |